CEO of Thermo Fisher Business Sues Company Over Earn-out Payments | GenomeWeb

This article has been corrected to clarify that although Thermo Fisher Scientific purchased NovaWave Technologies, it does not operate as a subsidiary of the firm.

NEW YORK (GenomeWeb News) – The CEO of a Thermo Fisher Scientific business is suing the company, alleging Thermo Fisher cheated him and other former shareholders millions of dollars in earn-out payments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.